Tolerance, not immunity, crucially depends on IL-2 (original) (raw)

• Nelson, B. H. & Willerford, D. M. Biology of the interleukin-2 receptor. Adv. Immunol. 70, 1–81 (1998).
  Article CAS PubMed Google Scholar
• He, Y. -W. & Malek, T. R. The structure and function of γc-dependent cytokines and receptors: regulation of T lymphocyte development and homeostasis. Crit. Rev. Immunol. 18, 503–524 (1998).
  Article CAS PubMed Google Scholar
• Parrish-Novak, J., Foster, D. C., Holly, R. D. & Clegg, C. H. Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses. J. Leukoc. Biol. 72, 856–863 (2002).
  CAS PubMed Google Scholar
• Waldmann, T. A., Dubois, S. & Tagaya, Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 14, 105–110 (2001).
  CAS PubMed Google Scholar
• Sadlack, B. et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75, 253–261 (1993).
  Article CAS PubMed Google Scholar
• Sadlack, B. et al. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur. J. Immunol. 25, 3053–3059 (1995).
  Article CAS PubMed Google Scholar
• Sadlack, B., Kuhn, R., Schorle, H., Muller, W. & Horak, I. Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4. Eur. J. Immunol. 24, 281–284 (1994). References 5–7 describe the lymphoproliferation and lethal autoimmunity that is associated with IL-2 deficiency and indicate that the main function of IL-2 is to control peripheral T-cell tolerance.
  Article CAS PubMed Google Scholar
• Suzuki, H., Duncan, G. S., Takimoto, H. & Mak, T. W. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor β chain. J. Exp. Med. 185, 499–505 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Willerford, D. M. et al. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521–530 (1995).
  Article CAS PubMed Google Scholar
• Lodolce, J. P. et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9, 669–676 (1998).
  Article CAS PubMed Google Scholar
• Kennedy, M. K. et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191, 771–780 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Morgan, D. A., Ruscetti, F. W. & Gallo, R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193, 1007–1008 (1976).
  Article CAS PubMed Google Scholar
• Gillis, S. & Smith, K. A. In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells. J. Exp. Med. 146, 468–482 (1977).
  Article CAS PubMed PubMed Central Google Scholar
• Taniguchi, T. et al. Structure and expression of a cloned cDNA for human interleukin-2. Nature 302, 305–310 (1983).
  Article CAS PubMed Google Scholar
• Shevach, E. M. Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18, 423–449 (2000).
  Article CAS PubMed Google Scholar
• Sakaguchi, S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101, 455–458 (2000).
  Article CAS PubMed Google Scholar
• Sakaguchi, S. Naturally arising CD4+ regulatory T Cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531–562 (2004).
  Article CAS PubMed Google Scholar
• Malek, T. R., Yu, A., Vincek, V., Scibelli, P. & Kong, L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17, 167–178 (2002). This paper was the first to provide direct evidence that IL-2- and/or IL-2R-dependent events have a role in the production of T Reg cells. T Reg -cell production and function was restored after thymus-specific expression of IL-2Rβ in IL-2rβ −/− mice, thereby preventing lethal autoimmunity. Identical suppression of autoimmunity was shown after adoptive transfer of wild-type T Reg cells into neonatal II-2rβ −/− mice. This protection was contingent on both the donor T Reg cells expressing a functional IL-2R and the host producing IL-2.
  Article CAS PubMed Google Scholar
• Papiernik, M., de Moraes, M. L., Pontoux, C., Vasseur, F. & Penit, C. Regulatory CD4 T cells: expression of IL-2Rα chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10, 371–378 (1998).
  Article CAS PubMed Google Scholar
• Thornton, A. M. & Shevach, E. M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287–296 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Almeida, A. R., Legrand, N., Papiernik, M. & Freitas, A. A. Homeostasis of peripheral CD4+ T cells: IL-2Rα and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J. Immunol. 169, 4850–4860 (2002).
  Article PubMed Google Scholar
• Klebb, G. et al. Interleukin-2 is indispensable for development of immunological self-tolerance. Clin. Immunol. Immunopathol. 81, 282–286 (1996).
  Article CAS PubMed Google Scholar
• Suzuki, H., Zhou, Y. W., Kato, M., Mak, T. W. & Nakashima, I. Normal regulatory αβ T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor β in vivo. J. Exp. Med. 190, 1561–1572 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Wolf, M., Schimpl, A. & Hunig, T. Control of T cell hyperactivation in IL-2-deficient mice by CD4+CD25− and CD4+CD25+ T cells: evidence for two distinct regulatory mechanisms. Eur. J. Immunol. 31, 1637–1645 (2001). This was the first paper to show that the abnormal behaviour of II-2 −/− T cells is controlled by T Reg cells. The transfer of II-2−/− CD4+ T cells to athymic nude mice led to uncontrolled clonal expansion of the donor cells, whereas the co-transfer of CD4+CD25+ T cells and II-2 −/− CD4+ T cells to nude mice prevented this abnormal proliferation.
  Article CAS PubMed Google Scholar
• Furtado, G. C., Curotto de Lafaille, M. A., Kutchukhidze, N. & Lafaille, J. J. Interleukin 2 signaling is required for CD4+ regulatory T cell function. J. Exp. Med. 196, 851–857 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Malek, T. R., Porter, B. O., Codias, E. K., Scibelli, P. & Yu, A. Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors. J. Immunol. 164, 2905–2914 (2000).
  Article CAS PubMed Google Scholar
• Burchill, M. A. et al. Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells. J. Immunol. 171, 5853–5864 (2003).
  Article CAS PubMed Google Scholar
• Snow, J. W. et al. Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice. J. Immunol. 171, 5042–5050 (2003).
  Article CAS PubMed Google Scholar
• Antov, A., Yang, L., Vig, M., Baltimore, D. & Van Parijs, L. Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance. J. Immunol. 171, 3435–3441 (2003).
  Article CAS PubMed Google Scholar
• Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969–1980 (1998).
  Article CAS PubMed Google Scholar
• Thornton, A. M., Piccirillo, C. A. & Shevach, E. M. Activation requirements for the induction of CD4+CD25+ T cell suppressor function. Eur. J. Immunol. 34, 366–376 (2004).
  Article CAS PubMed Google Scholar
• Tang, T. et al. In vitro expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199, 1455–1465 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Hoffmann, P., Eder, R., Kunz-Schughart, L. A., Andreesen, R. & Edinger, M. Large scale in vitro expansion of polyclonal human CD4+CD25hi regulatory T Cells. Blood 104, 895–903 (2004).
  Article CAS PubMed Google Scholar
• Bensinger, S. J. et al. Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J. Immunol. 172, 5287–5296 (2004).
  Article CAS PubMed Google Scholar
• Cozzo, C., Larkin, J. & Caton, A. J. Self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells. J. Immunol. 171, 5678–5682 (2003).
  Article CAS PubMed Google Scholar
• Gavin, M. A., Clarke, S. R., Negrou, E., Gallegos, A. & Rudensky, A. Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo. Nature Immunol. 3, 33–41 (2002).
  Article CAS Google Scholar
• Salomon, B. et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431–440 (2000).
  Article CAS PubMed Google Scholar
• Tang, Q. et al. CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J. Immunol. 171, 3348–3352 (2003).
  Article CAS PubMed Google Scholar
• Thornton, A. M., Donovan, E. E., Piccirillo, C. A. & Shevach, E. M. IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J. Immunol. 172, 6519–6523 (2004).
  Article CAS PubMed Google Scholar
• Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057–1061 (2003).
  Article CAS PubMed Google Scholar
• Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunol. 4, 330–336 (2003).
  Article CAS Google Scholar
• Khattri, R., Cox, T., Yasayko, S. A. & Ramsdell, F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nature Immunol. 4, 337–342 (2003).
  Article CAS Google Scholar
• Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303–310 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Read, S., Malmstrom, V. & Powrie, F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295–302 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Gorelik, L. & Flavell, R. A. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12, 171–181 (2000).
  Article CAS PubMed Google Scholar
• Powrie, F., Carlino, J., Leach, M. W., Mauze, S. & Coffman, R. L. A critical role for transforming growth factor-β but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RBlowCD4+ T cells. J. Exp. Med. 183, 2669–2674 (1996).
  Article CAS PubMed Google Scholar
• Asano, M., Toda, M., Sakaguchi, N. & Sakaguchi, S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184, 387–396 (1996).
  Article CAS PubMed Google Scholar
• Granucci, F. et al. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nature Immunol. 2, 882–888 (2001).
  Article CAS Google Scholar
• Smith, K. A. T-cell growth factor. Immunol. Rev. 51, 337–357 (1980).
  Article CAS PubMed Google Scholar
• He, Y. -W., Nakajima, H., Leonard, W. J., Adkins, B. & Malek, T. R. The common γ-chain of cytokine receptors regulates intrathymic T cell development at multiple stages. J. Immunol. 158, 2592–2599 (1997).
  CAS PubMed Google Scholar
• Depper, J. M., Leonard, W. J., Robb, R. J., Waldmann, T. A. & Greene, W. C. Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation. J. Immunol. 131, 690–696 (1983).
  CAS PubMed Google Scholar
• Malek, T. R., Ortega, G., Jakway, J. P., Chan, C. & Shevach, E. M. The murine IL 2 receptor. II. Monoclonal anti-IL 2 receptor antibodies as specific inhibitors of T cell function in vitro. J. Immunol. 133, 1976–1982 (1984).
  CAS PubMed Google Scholar
• Gillis, S., Gillis, A. E. & Henney, C. S. Monoclonal antibody directed against interleukin 2. I. Inhibition of T lymphocyte mitogenesis and the in vitro differentiation of alloreactive cytolytic T cells. J. Exp. Med. 154, 983–988 (1981).
  Article CAS PubMed Google Scholar
• Koretzky, G. A., Daniele, R. P., Greene, W. C. & Nowell, P. C. Evidence for an interleukin-independent pathway for human lymphocyte activation. Proc. Natl Acad. Sci. USA 80, 3444–3447 (1983).
  Article CAS PubMed PubMed Central Google Scholar
• Schorle, H., Holtschke, T., Hunig, T., Shimpl, A. & Horak, I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352, 621–624 (1991).
  Article CAS PubMed Google Scholar
• Razi-Wolf, Z., Hollander, G. A. & Reiser, H. Activation of CD4+ T lymphocytes from interleukin 2-deficient mice by costimulatory B7 molecules. Proc. Natl Acad. Sci. USA 93, 2903–2908 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Van Parijs, L. et al. Functional responses and apoptosis of CD25 (IL-2Rα)-deficient T cells expressing a transgenic antigen receptor. J. Immunol. 158, 3738–3745 (1997).
  CAS PubMed Google Scholar
• Malek, T. R., Yu, A., Scibelli, P., Lichtenheld, M. G. & Codias, E. K. Broad programming by IL-2 receptor signaling for extended growth to multiple cytokines and functional maturation of antigen-activated T cells. J. Immunol. 166, 1675–1683 (2001).
  Article CAS PubMed Google Scholar
• Appleman, L. J., Berezovskaya, A., Grass, I. & Boussiotis, V. A. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J. Immunol. 164, 144–151 (2000). This paper shows that co-stimulation through CD28 regulates progression through the G1 phase of the cell cycle in an IL-2-independent manner. In the absence of IL-2, some T cells arrest at the G1–S transition, but a considerable number progress through S phase, indicating that CD28 mediates some T-cell proliferation in an IL-2-independent manner.
  Article CAS PubMed Google Scholar
• Cao, X. et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity 2, 223–238 (1995).
  Article CAS PubMed Google Scholar
• Cote-Sierra, J. et al. Interleukin 2 plays a central role in TH2 differentiation. Proc. Natl Acad. Sci. USA 101, 3880–3885 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Lenardo, M. J. Interleukin-2 programs αβ T lymphocytes for apoptosis. Nature 353, 858–861 (1991).
  Article CAS PubMed Google Scholar
• Kneitz, B., Herrmann, T., Yonehara, S. & Schimpl, A. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice. Eur. J. Immunol. 25, 2572–2577 (1995).
  Article CAS PubMed Google Scholar
• Van Parijs, L. & Abbas, A. K. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280, 243–248 (1998).
  Article CAS PubMed Google Scholar
• Kung, J., Beller, D. & Ju, S. Lymphokine regulation of activation-induced apoptosis in T cells of IL-2 and IL-2Rβ knockout mice. Cell. Immunol. 185, 158–163 (1998).
  Article CAS PubMed Google Scholar
• Zheng, L., Trageser, C. L., Willerford, D. M. & Lenardo, M. J. T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death. J. Immunol. 160, 763–769 (1998).
  CAS PubMed Google Scholar
• Kundig, T. M. et al. Immune responses in interleukin-2-deficient mice. Science 262, 1059–1061 (1993). This paper shows that normal in vivo immune responses occur in IL-2-deficient mice, including the induction of protective CTL and antibody responses after viral infection. Both T H cells and NK cells showed reduced activity but were still functionally active. This study was the first to question the idea that IL-2 is essential for T-cell immunity in vivo.
  Article CAS PubMed Google Scholar
• Steiger, J., Nickerson, P. W., Steurer, W., Moscovitch-Lopatin, M. & Strom, T. B. IL-2 knockout recipient mice reject islet cell allografts. J. Immunol. 155, 489–498 (1995).
  CAS PubMed Google Scholar
• Bachmann, M. F. et al. Antiviral immune responses in mice deficient for both interleukin-2 and interleukin-4. J. Virol. 69, 4842–4846 (1995).
  CAS PubMed PubMed Central Google Scholar
• Nishimura, H. et al. Mice lacking interleukin-2 (IL-2)/IL-15 receptor β chain are susceptible to infection with avirulent Salmonella enterica subsp. enterica serovar choleraesuis but mice lacking IL-2 are resistant. Infect. Immun. 69, 1226–1229 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Suzuki, H., Hayakawa, A., Bouchard, D., Nakashima, I. & Mak, T. W. Normal thymic selection, superantigen-induced deletion and Fas-mediated apoptosis of T cells in IL-2 receptor β-chain deficient mice. Int. Immunol. 9, 1367–1374 (1997).
  Article CAS PubMed Google Scholar
• D'Souza, W. N. & Lefrancois, L. IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion. J. Immunol. 171, 5727–5735 (2003).
  Article CAS PubMed Google Scholar
• Leung, D. T., Morefield, S. & Willerford, D. M. Regulation of lymphoid homeostasis by IL-2 receptor signals in vivo. J. Immunol. 164, 3527–3534 (2000).
  Article CAS PubMed Google Scholar
• D'Souza, W. N., Schluns, K. S., Masopust, D. & Lefrancois, L. Essential role for IL-2 in the regulation of antiviral extralymphoid CD8 T cell responses. J. Immunol. 168, 5566–5572 (2002).
  Article CAS PubMed Google Scholar
• Yu, A. et al. Efficient induction of primary and secondary T cell-dependent immune responses in vivo in the absence of functional IL-2 and IL-15 receptors. J. Immunol. 170, 236–242 (2003). This paper shows that T-cell immunity to skin grafts, T H -cell-dependent antibody responses and T-cell mediated responses to viruses are mostly functional in II-2rβ −/− mice, in which the mature T cells are peripherally non-responsive to IL-2 and IL-15. Because these mice were made free of autoimmune disease by correcting T Reg -cell production, the resulting immune responses cannot be the result of improper activation, a property that is typically associated with IL-2- or IL-2R-deficiency.
  Article CAS PubMed Google Scholar
• Kuhn, R., Rajewsky, K. & Muller, W. Generation and analysis of interleukin-4 deficient mice. Science 254, 707–710 (1991).
  Article CAS PubMed Google Scholar
• Cousens, L. P., Orange, J. S. & Biron, C. A. Endogenous IL-2 contributes to T cell expansion and IFN-γproduction during lymphocytic choriomeningitis virus infection. J. Immunol. 155, 5690–5699 (1995).
  CAS PubMed Google Scholar
• Su, H. C. et al. CD4+ and CD8+ T cell interactions in IFN-γ and IL-4 responses to viral infections: requirements for IL-2. J. Immunol. 160, 5007–5017 (1998).
  CAS PubMed Google Scholar
• Blattman, J. N. et al. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nature Med. 9, 540–547 (2003).
  Article CAS PubMed Google Scholar
• Cheng, L. E. & Greenberg, P. D. Selective delivery of augmented IL-2 receptor signals to responding CD8+ T cells increases the size of the acute antiviral response and of the resulting memory T cell pool. J. Immunol. 169, 4990–4997 (2002).
  Article PubMed Google Scholar
• Cheng, L. E., Ohlen, C., Nelson, B. H. & Greenberg, P. D. Enhanced signaling through the IL-2 receptor in CD8+ T cells regulated by antigen recognition results in preferential proliferation and expansion of responding CD8+ T cells rather than promotion of cell death. Proc. Natl Acad. Sci. USA 99, 3001–3006 (2002). References 79–81 report the effect of systemic IL-2 during the clonal expansion, contraction and memory phases of in vivo T-cell responses to viral infection. IL-2 showed its greatest benefit during the contraction phase of the response, in which it increased proliferation and survival of long-lived virus-specific T cells.
  Article CAS PubMed PubMed Central Google Scholar
• Li, X. C. et al. IL-15 and IL-2: a matter of life and death for T cells in vivo. Nature Med. 7, 114–118 (2001).
  Article CAS PubMed Google Scholar
• Sepulveda, H., Cerwenka, A., Morgan, T. & Dutton, R. W. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation. J. Immunol. 163, 1133–1142 (1999).
  CAS PubMed Google Scholar
• Croft, M. Costimulation of T cells by OX40, 4-1BB, and CD27. Cytokine Growth Factor Rev. 14, 265–273 (2003).
  Article CAS PubMed Google Scholar
• Changelian, P. S. et al. Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor. Science 302, 875–878 (2003).
  Article CAS PubMed Google Scholar
• Lantz, O., Grandjean, I., Matzinger, P. & Di Santo, J. γ chain required for naive CD4+ T cell survival but not antigen proliferation. Nature Immunol. 1, 54–58 (2000).
  Article CAS Google Scholar
• Levings, M. K., Sangregorio, R. & Roncarolo, M. G. Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193, 1295–1302 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Dieckmann, D., Plottner, H., Berchtold, S., Berger, T. & Schuler, G. Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood. J. Exp. Med. 193, 1303–1310 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Jonuleit, H. et al. Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193, 1285–1294 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Stephens, L. A., Mottet, C., Mason, D. & Powrie, F. Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 31, 1247–1254 (2001).
  Article CAS PubMed Google Scholar
• Taams, L. S. et al. Human anergic/suppressive CD4+CD25+ T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 31, 1122–1131 (2001).
  Article CAS PubMed Google Scholar
• Baecher-Allan, C., Brown, J. A., Freeman, G. J. & Hafler, D. A. CD4+CD25hi regulatory cells in human peripheral blood. J. Immunol. 167, 1245–1253 (2001). References 87–92 are the first reports to show that human CD4+CD25+ T cells isolated from peripheral blood have in vitro properties and suppressor functions similar to their mouse counterparts.
  Article CAS PubMed Google Scholar
• Roifman, C. M. Human IL-2 receptor α chain deficiency. Pediatr. Res. 48, 6–11 (2000).
  Article CAS PubMed Google Scholar
• Davey, R. T. Jr et al. Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: a randomized controlled trial. JAMA 284, 183–189 (2000).
  Article CAS PubMed Google Scholar
• Kovacs, J. A. et al. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N. Engl. J. Med. 335, 1350–1356 (1996).
  Article CAS PubMed Google Scholar
• Atkins, M. B. Interleukin-2: clinical applications. Semin. Oncol. 29, 12–17 (2002).
  Article CAS PubMed Google Scholar
• Yang, J. C. et al. Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer. J. Clin. Oncol. 21, 3127–3132 (2003).
  Article CAS PubMed Google Scholar
• Ku, C. C., Murakami, M., Sakamoto, A., Kappler, J. & Marrack, P. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 288, 675–678 (2000).
  Article CAS PubMed Google Scholar
• Murakami, M., Sakamoto, A., Bender, J., Kappler, J. & Marrack, P. CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc. Natl Acad. Sci. USA 99, 8832–8837 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Sereti, I. et al. IL-2 induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation. Blood 104, 775–780 (2004).
  Article CAS PubMed Google Scholar
• McHugh, R. S. & Shevach, E. M. Depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J. Immunol. 168, 5979–5983 (2002).
  Article CAS PubMed Google Scholar
• Foss, F. M. Interleukin-2 fusion toxin: targeted therapy for cutaneous T cell lymphoma. Ann. NY Acad. Sci. 941, 166–176 (2001).
  Article CAS PubMed Google Scholar
• Onizuka, S. et al. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody. Cancer Res. 59, 3128–3133 (1999).
  CAS PubMed Google Scholar
• Sutmuller, R. P. et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J. Exp. Med. 194, 823–832 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Shimizu, J., Yamazaki, S. & Sakaguchi, S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 163, 5211–5218 (1999).
  CAS PubMed Google Scholar
• Liyanage, U. K. et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 169, 2756–2761 (2002).
  Article CAS PubMed Google Scholar
• Woo, E. Y. et al. Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J. Immunol. 168, 4272–4276 (2002).
  Article CAS PubMed Google Scholar
• Ichihara, F. et al. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin. Cancer Res. 9, 4404–4408 (2003).
  PubMed Google Scholar
• Wolf, A. M. et al. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin. Cancer Res. 9, 606–612 (2003).
  PubMed Google Scholar
• Sasada, T., Kimura, M., Yoshida, Y., Kanai, M. & Takabayashi, A. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 98, 1089–1099 (2003).
  Article PubMed Google Scholar
• Church, A. C. Clinical advances in therapies targeting the interleukin-2 receptor. QJM 96, 91–102 (2003).
• Waldmann, T. A. & O'Shea, J. The use of antibodies against the IL-2 receptor in transplantation. Curr. Opin. Immunol. 10, 507–512 (1998).
  Article CAS PubMed Google Scholar
• Shapiro, A. M. et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343, 230–238 (2000).
  Article CAS PubMed Google Scholar